Basdevant, A <br/><br/>
Hepatic lipase activity during oral and parenteral 17 beta-estradiol replacement therapy: high-density lipoprotein increase may not be antiatherogenic.  [electronic resource] 

 -  Fertility and sterility  Jun 1991 
 - 1112-7 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0015-0282 
<br/><br/><label>Standard No.: </label>10.1016/s0015-0282(16)54361-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Cutaneous<br/>Administration, Oral<br/>Analysis of Variance<br/>Apolipoproteins--blood<br/>Arteriosclerosis--prevention & control<br/>Cholesterol--blood<br/>Cholesterol, HDL--blood<br/>Cholesterol, LDL--blood<br/>Estradiol--administration & dosage<br/>Estrogen Replacement Therapy<br/>Female<br/>Follicle Stimulating Hormone--blood<br/>Humans<br/>Isoenzymes--blood<br/>Lipase--blood<br/>Lipoproteins, HDL--blood<br/>Liver--enzymology<br/>Luteinizing Hormone--blood<br/>Menopause<br/>Phospholipids--blood